A collaborative effort among international research teams provides the most definitive statement yet on the usefulness of ...

Across multiple randomized controlled trials, Artificial Intelligence (AI) interventions consistently proved effective as ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a “polypill” combination of three medications typically prescribed for heart failure, once daily for six months, ...

The answer is very clear that if you have MI and preserved EF, there is no benefit of using a beta-blocker. Sripal Bangalore ...

AI's effectiveness varies critically based on the clinical settings; studies in high-volume, population-based contexts, such ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...

Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a "polypill" combination of three ...

Tempus AI shows strong Q3 growth with 85% higher sales, robust oncology and data licensing momentum, and attractive 7.5x ’26 ...

PhD Defense: Improving Clinical Management of Rheumatic Heart Disease in Developing Countries: Focus on Indonesia ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 2 CADENCE study evaluating WINREVAIR™ (sotatercept-csrk) in adults for ...

For the first time, astronomers have detected a massive eruption — severe enough to devastate the atmosphere of a nearby ...